Eleonora Russo

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

S. Prato, G. Penno, E. Russo, 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction.

G. Niccoli, F. Crea, F. Andreotti, 2010, International journal of cardiology.

Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes

E. Bonora, A. Avogaro, G. Sesti, 2022, Cardiovascular Diabetology.

Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.

S. Del Prato, G. Daniele, L. Giusti, 2018, Journal of diabetes and its complications.

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

F. Burzotta, G. Niccoli, I. Porto, 2008, European heart journal.

Predictors of persistence of functional mitral regurgitation after cardiac resynchronization therapy: Review of literature

M. Braccio, E. Russo, G. Russo, 2022, World journal of cardiology.